Study Objectives: Stressful events can directly produce significant alterations in subsequent sleep, in particular rapid eye movement sleep (REM); however, the neural mechanisms underlying the process are not fully known. Here, we investigated the role of the basolateral nuclei of the amygdala (BLA) in regulating the effects of stressful experience on sleep. Methods: We used optogenetics to briefly inhibit glutamatergic cells in BLA during the presentation of inescapable footshock (IS) and assessed effects on sleep, the acute stress response, and fear memory. c-Fos expression was also assessed in the amygdala and the medial prefrontal cortex (mPFC), both regions involved in coping with stress, and in brain stem regions implicated in the regulation of REM. Results: Compared to control mice, peri-shock inhibition of BLA attenuated an immediate reduction in REM after IS and produced a significant overall increase in REM. Moreover, upon exposure to the shock context alone, mice receiving peri-shock inhibition of BLA during training showed increased REM without altered freezing (an index of fear memory) or stress-induced hyperthermia (an index of acute stress response). Inhibition of BLA during REM under freely sleeping conditions enhanced REM only when body temperature was high, suggesting the effect was influenced by stress. Peri-shock inhibition of BLA also led to elevated c-Fos expression in the central nucleus of the amygdala and mPFC and differentially altered c-Fos activity in the selected brain stem regions. Conclusions: Glutamatergic cells in BLA can modulate the effects of stress on REM and can mediate effects of fear memory on sleep that can be independent of behavioral fear.
INTRODUCTION
There has been long-standing and continued interest in the role that sleep may play in memory consolidation. Complementary questions regarding the impact that learning and memories, particularly those associated with emotionally charged and stressful events, can have on sleep have received much less attention. These questions have tremendous importance for posttraumatic stress disorder (PTSD), which can involve aberrant fear processing, 1 is linked to stress-related alterations in sleep 2, 3 and is characterized by continuing disturbances of sleep and arousal. 4, 5 There are also implications for other anxiety disorders and depression which are associated with abnormalities in memory 6 and sleep. 7 Rapid eye movement sleep (REM) can be highly affected by stress and fear. However, the relationships among stress, fear memory, and sleep are complex, as studies in rodents demonstrate that experiencing stress or fear is not predictive of subsequent REM. This is most apparent in training with inescapable footshock (IS; an uncontrollable stressor) which can reduce subsequent REM, whereas training with escapable footshock (ES) or avoidable footshock (controllable stressors) can be followed by increases in REM. [8] [9] [10] Indices of stress, such as stress-induced hyperthermia (SIH), 11 and fear memory, such as behavioral freezing, 12 can be virtually identical in situations that produce increases or decreases in REM. 10, 13 Outbred rats can show significant variations in poststress REM after very similar stressors, thereby suggesting that individual differences in stress responsivity are also involved in mediating the effects of stress on sleep. 10 Importantly, evoking fear memories produce changes in sleep similar to those produced by the initial fearful event. 9, 10 Together, these findings suggest that the ability of fearful events to produce differential sleep outcomes reflects unique learning processes that are not accounted for by current concepts of fear conditioning. The significance of the differences in stress-induced alterations in REM has not been established; however, REM has been hypothesized to play a role in "decoupling" memory from its emotional charge 14, 15 and aiding in processing of memory for trauma. 2, 3 Thus, poststress increases in REM may play an important role in adaptive responding to stress.
The neural processes that enable outwardly similar stress and fear responses but lead to significant differences in poststress sleep are not known. However, the amygdala, which is essential for fear responses (reviewed in 16 ), also mediates the effects of stress and fearful memories on REM (reviewed in 17 ). Evidence from studies using localized pharmacological manipulations demonstrate roles for both the central (CNA) 18 and the basolateral (BLA) 19 nuclei of the amygdala in mediating these effects. BLA also appears critical for forming fear memories that can differentially impact sleep. Unfortunately, experiments conducted to date have not delineated the initial neural responses that lead to differences in poststress REM.
Significance Statement
Stressful life experiences can alter sleep and lead to the formation of memories capable of altering sleep far into the future. Here we show that brief, perishock, optogenetic inhibition of glutamatergic cells in the basolateral nuclei of the amygdala (BLA), a region involved in linking emotional values to sensory input, can lead to enhanced poststress rapid eye movement sleep (REM). Inhibition of BLA can also alter the effects of fear memory on REM and neuronal activity in brain regions involved in regulating stress and arousal without altering the stress response or behavioral fear. These data demonstrate that BLA can modulate the effects of stress and fear on sleep in ways that may have significance for stress-related emotional disorders.
In this study, we utilized an inhibitory optogenetic construct (AAV-CaMKIIα-eNpHR3.0-eYFP; NpHR) using a calcium-calmodulin-dependent kinase IIα (CaMKIIα) promoter to target glutamatergic projection neurons in BLA in a time-specific fashion. These neurons are the primary class of neurons in BLA and virtually all express CaMKIIα. 20, 21 We first affirmed specificity of the optogenetic manipulation immunohistochemically and the ability to alter glutamate release in BLA neurochemically. For functional studies, we inhibited BLA activity for 10 s around the time (peri-shock) of shock presentation in an extensive fear-conditioning paradigm and determined the effects on fear memory, the stress response, and sleep. The impact of BLA inhibition on neuronal activity (using c-Fos as a marker) was also assessed in regions implicated in mediating the effects of stress and fear on sleep. Finally, the effects of BLA inhibition on sleep under home cage conditions were evaluated. These data demonstrate that even brief alterations in the activity of BLA glutamatergic neurons can impact the effects of stress and fear memory on sleep, without significantly altering either behavioral fear or the stress response.
METHODS

Subjects
Adult male C57BL/6J mice were obtained from Charles River (Raleigh, NC). The mice were 8-9 weeks old and weighed 20-25 g at arrival and were kept in a colony room with food and water available ad libitum. The colony room was maintained on a 12:12 light-dark cycle and ambient temperature at 24°C ± 1.5°C. After at least 1 week of acclimation, the animals were individually housed before surgery was conducted. Throughout the experimental procedures, measures were taken to minimize unnecessary pain and discomfort of the animals. All procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Experimental Animals and were approved by Eastern Virginia Medical School's Institutional Animal Care and Use Committee.
Virus Vector Construct
Purified adeno-associated virus preparations (AAV5) containing -CaMKIIα-eNpHR3.0-eYFP-WPRE (NpHR), CaMK IIα-hChR2(H134R)-eYFP-WPRE (ChR2), or CaMKIIα-eYFP-WPRE (eYFP) were obtained from the UNC Virus Vector Core Facility (University of North Carolina at Chapel Hill). NpHR enables selective targeting of a subpopulation of glutamatergic neurons, and the construct has been used in studies examining the role of the amygdala in the regulation of anxiety behaviors 22 and fear learning 23 as well as in studies of the influence of BLA on other brain regions. 24 The final viral concentration for injection was 1.5 × 10 12 virus molecules/ml in 350 mM NaCl, 5% D-Sorbitol.
Surgical Procedures
All surgical procedures were conducted during the light period with the mice under isofluorane anesthesia as inhalant (5% induction; 2% maintenance). All animals received prophylactic potassium penicillin (25 IU/g), gentamicin (0.005 mg/g), and dexamethasone (0.0005 mg/g) subcutaneously. Mice in the sleep studies were implanted intraperitoneally with telemetry transmitters (ETA-F10 or ETA-F20, Data Sciences, St. Paul, MN) to measure electroencephalography (EEG), activity, and core body temperature. Electrode leads from the transmitter body were led subcutaneously to the head, and the free ends were placed into holes drilled in the skull to record cortical EEG (approximate coordinates from Bregma: 1.5/−3.5 mm AP, ± 1.5 mm ML). Microinjection cannulae were stereotaxically placed bilaterally above BLA (−1.5 mm AP, ± 2.9 mm ML, −4.7 mm DV) for administration of constructs containing either NpHR or eYFP only for control experiments. We used 26-gauge injector cannulae connected to a syringe pump (BSP-99M, Braintree Scientific Inc., Braintree, MA) at a flow rate of 0.1 µl/min. Each injection delivered 0.5 µl of virus vector. The cannulae remained in place for an additional 5 to 10 min to allow diffusion of viral particles away from the injection site. Custom-made optic probes (200 µm, conical tip, mated to metal or ceramic ferules) were then implanted directly above the injection sites and secured to the skull using dental cement. For studies employing the neurotransmitter release assay, similar procedures were used to inject mice with a mixture of NpHR and ChR2; these mice did not receive optic fiber implants. Ibuprofen (30 mg/kg, oral) was continuously available in each animal's drinking water for 24-48 h preoperatively and for a minimum of 72 h postoperatively to alleviate potential operative pain. The animals were given 2 weeks for postsurgery recovery and an additional 2-4 weeks to allow viral transduction. During the period, the animals were kept undisturbed except for weekly bedding changes.
Peri-Shock Inhibition of BLA In Vivo
Methods for fear conditioning and fear memory testing have been described in Machida et al. 25 After baseline recordings were obtained, the mice were connected bilaterally to optic fiber cables and placed in a shock chamber (Coulbourn Instruments) for shock training (ST). DataWave Experimenter's Workbench (Data Wave Technologies, Loveland, CO) was used to control the timing and duration of footshock and light. Footshock was produced via Coulbourn Precision Regulated Animal Shockers (Model E13-14, Coulbourn Instruments, Whitehall, PA) and administered via grid floors in the shock chamber. Inhibitory light (532nm) was produced via LEDs (Model: LEDFRJ-B/G_FC; Doric Lenses, Inc., Quebec, Canada) or 100-200 mW lasers (Shanghai Laser & Optics Century Co., Ltd., Shanghai, China). Light output was measured by an optical power meter and adjusted to ~10 mW at the optic fiber tip. Procedures started at the seventh hour after lights on. The ST procedure lasted 30 min (5-min preshock period; 20 shock presentations [0.5 mA, 0.5 s duration, 1-min interval] and a 5-min postshock period). Inhibitory light stimulation to activate NpHR started 5 s prior to each shock onset and continued for 5 s after shock onset (peri-shock light stimulation). One week after ST (context day 1 [CTX1]) or 3 weeks after ST (context day 2 [CTX2]), the animals were reexposed to the shock chamber for 30 min without shock/light being presented to test long-term memory of the stressful experience. Training and test sessions were conducted at the same circadian time across days and videotaped for subsequent scoring of freezing.
Cortical EEG Recording and Determination of Behavioral State
Individual cages were placed on a telemetry receiver (Data Sciences, RPC-1) and signals (EEG, core body temperature, and transistor-transistor logic [TTL pulses]) from the transmitter were processed and collected by a software (Data Sciences) for subsequent off-line data analyses. TTL pulses generated by the telemetry system when the mice moved around in their cages were used as a measure of activity. Sleep and wakefulness of the animals were visually scored by a trained observer based on EEG and activity in 10-s epochs using a scoring program (Sleep Sign for Animal, Kissei, Nagano, Japan) as described previously. 25, 26 Briefly, each epoch was scored as wakefulness with moving (AW, with activity recorded in epoch), quiet wakefulness (QW, no activity during epoch), NREM, or REM. During NREM sleep, the EEG was characterized as high amplitude slow waves, while REM was characterized as regularly spaced lower amplitude wave and increased theta activity. To establish baseline sleep levels, cortical EEG was telemetrically recorded uninterrupted for 20 h. We affirmed that NpHR alone did not differentially impact sleep. Analysis of variance (ANOVA) found no differences between eYFP and NpHR groups in the sleep parameters that we assessed. This included hourly and total 20-h REM amounts for eYFP and NpHR groups (20 h totals: 64.25 ± 2.30 min and 68.13 ± 1.74 min, respectively).
Scoring of Freezing
Freezing, defined as a rigid posture with the complete absence of visible movement except for respiration, has been used to evaluate fear memory, with greater freezing being interpreted as an indication of a stronger fear reaction. 12 Freezing was scored by a trained observer for the 5-min preshock period during ST and for the initial 5 min during the CTX1 and CTX2. The percentage time of the freezing response (FR%) was calculated as = freezing time / observed time × 100 for each animal for each observation period.
Measurement of Stress-Induced Hypothermia
Core body temperature was automatically recorded by the intraperitoneally implanted telemetry transmitter. A stress-induced increase in body temperature (SIH, also called psychogenic fever) occurs in all mammals including humans in preparation for fight-or-flight reactions. 11 The time course of SIH parallels that of hypothalamic-pituitary-adrenal (HPA) axis activation and has been used as a measure of acute stress response.
11 SIH was defined as the difference in body temperature between stress condition (ST, CTX1 and CTX2; T 2 ) and basal (T 1 ) measurements (ΔT = T 2 − T 1 ). 11 Under nonstress conditions (basal), mean core body temperature was similar for the eYFP and NpHR mice (35.66°C ± 0.07°C and 35.76°C ± 0.06 °C, respectively).
Procedure to Test Effects of Inhibition of BLA on Sleep in Home Cages
The test procedure started at the second hour after lights on and lasted for 6 h during the light period of 3 consecutive days. During the procedure, the mice were tethered by 45-cm-long optic cables coupled with optic probes bilaterally implanted in BLA. The mice received inhibitory light stimulation during spontaneous sleep but were otherwise undisturbed and moved freely in their home cage. Food and water were available ad libitum. Mouse behavior and the EEG were monitored in real time on screens installed in the adjacent room and used to determine behavioral states and to aid in discriminating sleep stages. Administration and duration of light were manually controlled using a Hybrid Multi-LED driver. On one of the days, the animals were kept tethered to optic fibers but did not receive light; data collected on that day were later used as treatment control (tethered). On the other 2 days, the animals received light stimulation during either spontaneous REM (REM+) or NREM (NREM+). In 6-h testing, measures were taken to minimize stress involving handling and mild restraint. Increase in core body temperature (SIH) was persistently observed during the first 1 h after being hooked-up; thus, this period was used for animals to habituate to the optic cables (pretest). At the beginning of the second hour (H1), and during H2 and H4, multiple trials of light presentation were administered. No light administration occurred during H3 and H5 (trial control). Each trial of light stimulation lasted for 10 s, and an average of 10 trials were applied in each hour. When the mice did not show any spontaneous REM sleep during a test hour, optogenetic light trials were not performed and that hour was excluded from the analysis.
Neurotransmitter Release Assay
The animals received microinjections of a mixture of NpHR and ChR2 vectors, as described in surgical procedure. For the assay, the mice were anesthetized with 15% halothane in mineral oil, and brains were rapidly removed and placed into icecold phosphate-buffered saline (PBS), pH 7.4. One-mm-thick coronal slices were made using a mouse brain matrix (Brain Research Laboratories, Waban, MA), and BLA was dissected with custom-made tissue punchers (1-mm diameter) using visual landmarks aided by a stereotaxic atlas. 27 The excised tissues were minced to increase surface area of the slices for radioactive-tagged glutamate uptake and oxygen/glucose supply. Synaptosome preparation was conducted as described previously by Lonart et al. 28 Briefly, the excised tissues were placed in ice-cold isotonic sucrose solution (0.32 M sucrose, 100 µM EDTA, 5 mM HEPES, pH 7.4) and homogenized at 900 rpm with a motor-driven homogenizer. Debris and nuclei were pelleted by differential centrifugation at 900×g at 4°C for 10 min, and the supernatant was then centrifuged at 11,500×g at 4°C for 20 min to pellet the synaptosomes. The synaptosomes were resuspended in ice-cold aerated (95% O 2, 5% CO 2 ) Krebsbicarbonate-HEPES buffer (KBH; 118 mM NaCl, 13.5 mM KCl, 1.25 mM CaCl 2 , 1.2mM MgSO 4 , 1.2 mM KH 2 PO 4 , 25 mM NaCO 3 , 5 mM HEPES-NaOH (pH 7.4), 11.5 mM D-glucose) and equilibrated on ice for at least 30 min.
Neurotransmitter release assay was conducted as described previously by Lonart et al. 28 Briefly, slice preparations were incubated in a solution containing 3.8 µM o C in freshly bubbled KBH. Afterward, they were transferred to a superfusion chamber containing a glass fiber filter (GF/B) covered with 25 µl of 50% Sephadex slurry to superfuse with continuously bubbled KBH at 35 o C. After a 45-min washing period to remove any un-incorporated radioisotopes, 3-min fractions of the superfusate were then collected from the slices to determine radioactivity efflux as a measure of glutamate release. Studies with synaptosomes were identical except that the washing period was 12 min and fractions of the superfusate were collected for 1 min. Release was optogenetically induced by exposing the superfusion chambers to either blue light (473 nm) alone or a combination of blue and green lights (532 nm) produced by 100-200 mW lasers (Shanghai Laser & Optics Century Co., Ltd, Shanghai, China). Radioactivity in the eluted fractions and in the slices/synaptosomes remaining at the end of the experiment were determined with a liquid scintillation spectrometer (LS 3801, Beckman Instruments, Inc., Fullerton, CA). Release was expressed as the fractional release rate, calculated as the fraction of radioactivity released, divided by the amount remaining in the slice or synaptosome preparation at that particular time point.
Histology
Perfusion, Fixation, and Sectioning
Following behavioral experiments, mice were deeply anesthetized with isofluorane and perfused transcardially with cold PBS, pH 7.4, followed by 4% paraformaldehyde (PFA) in PBS. Brains were removed and postfixed in 4% PFA for 24 h and then transferred to 30% sucrose for 24-48 h to cryoprotect. Brain tissue was then snap-frozen in isopentane placed on liquid nitrogen. Coronal sections were cut from frozen brains on a cryostat.
Direct Detection of Virus Expression
Sections (40-µm thick) were made through the amygdala and mounted on gelatin-coated slides. Expression of eYFP (spectra: Absorption 514 nm, Emission 527) in BLA was then examined using a fluorescent microscope (Nikon Eclipse E800 with 4×, 10× objectives) equipped with a filter to detect eYFP expression (filter spectra: Exciter 500/20, Dichroic 515 LP, Emitter 535/30, Nikon yellow GFP BP HYQ). Mice showing no eYFP expression in BLA due to faulty microinjections and mice showing cannula/optic fiber placements outside BLA were excluded from the analysis.
CaMKIIα and GABA Immunofluorescence
A separate set of sections was prepared through the amygdala region, and sections (25-µm thick) were collected to use free-floating methods for immunofluorescence as described previously. 29, 30 Sections were labeled either with rabbit monoclonal anti-CaMKII (1:250, EP1829Y, Abcam, Cambridge, MA) or mouse monoclonal anti-GABA (1:2000, A0130, SigmaAldrich, St. Louis, MO) followed by the fluorescent secondary antibodies goat anti-rabbit Alexa Fluor 568 (1:200, Invitrogen) or goat anti-mouse Alexa Fluor 430 (1:200, Invitrogen), respectively. All blocking steps were done in PBS containing 3% normal goat serum (NGS, G9023, Sigma-Aldrich), 2% nonfat dry milk and 0.1% Triton X-100. Sections were incubated in the primary antibody for 24 h at 4°C and incubated in the secondary antibody for 1 h at room temperature in dark. Sections were then mounted and coverslipped with antifade reagent (Invitrogen). Randomly selected samples were used as a blank control which was processed identically but did not contain primary antibodies. Omission of the primary antibodies resulted in complete loss of fluorescent signals.
c-Fos Immunohistochemistry
After ST, the animals were returned to their home cages and killed 2 h after. Brains were removed and fixed as described earlier. Coronal sections (40-µm thick) were cut from frozen brains, and every fifth section was collected as a sample. Freefloating methods were used. All blocking steps were done in 0.01 M PBS, pH 7.4, with 1-2% NGS. Endogenous peroxidase activity was tested by a peroxidase detection system using Vector ABC kit, and when the activity was detected, the sections were incubated in 0.3% hydrogen peroxide (H 2 O 2 )-2% NGS in PBS for 30 min at room temperature to eliminate peroxidase to block nonspecific binding sites. Sections were incubated for 24-48 h at 4°C with rabbit polyclonal c-Fos antibody (50 µg/ml, ab102699, Abcam, Cambridge, MA) in PBS containing 0.3% Triton X-100 and 2% NGS. Sections were then incubated for 2 h at room temperature with biotinylated goat anti-rabbit secondary antibody (1:200, Vector Laboratories) in PBS containing 2% NGS. Subsequently, the sections were washed and incubated for 1 h at room temperature with horseradish peroxidase avidin-biotin complex (1:100 ABC reagent in PBS-TX, Avidin-Biotin Complex, Vector ABC kit, Vector Laboratories, Burlingame, CA). Sections were then mounted to slides and incubated with DAB-Nickel (DAB peroxidase substrate kit, SK-4100, Vector Laboratories) for 2 min. Randomly selected samples were used as a blank control which was processed identically but did not contain c-Fos primary antibody. Omission of the primary antibody resulted in complete loss of staining.
Data Imaging and Quantification
Regions of interest (ROIs) were manually delineated using a mouse brain atlas (Paxinos and Franklin, 2 nd edition 27 ), and each was evaluated approximately around: 3.0 to 1.5 mm AP for mPFC, −3.3 to −0.3 for amygdala, −4.0 to −5.3 for dorsal raphe nucleus (DRN), −5.3 to −5.8 for locus coeruleus (LC), −5.0 to −5.5 for laterodorsal tegmental nucleus (LDTg), −4.2 to −4.8 for pedunculopontine tegmental nucleus (PPTg), and −3.3 to −0.3 for somatosensory cortex (SC). Immunoreactive cells were visualized using a Nikon Eclipse E800 microscope at 4×, 10×, and 40× objective magnification. Photomicrographs of the ROIs were taken using SPOT RT software v. 3.1 (Diagnostic Instruments, Inc., Sterling Heights, MI). Border delineation, cell counting, and area measurements were done with a Fiji distribution of ImageJ (Fiji Life-Line version, 2014 Nov 25). At least two measurements along the AP axis were made for each ROI for each animal, and mean values were used for data analysis.
Data Analysis
Data were analyzed using Sigma Plot 12.0 (Systat Software, Inc., San Jose, CA) by mixed factors ANOVA procedures, and post hoc comparisons were conducted using Tukey tests when appropriate. For within-subject analysis, repeated measures ANOVA was used. In cases where the equal variance test failed, the data were analyzed using the Kruskal-Wallis ANOVA on ranks. Differences were considered significant at p < .05.
RESULTS
NpHR Expression Was Specific to BLA Glutamatergic Cells and Was Not Observed in Interneurons
To affirm specificity, we histologically studied coronal sections including the amygdala. As seen in Figure 1A , yellow fluorescent protein (eYFP) used to localize the injections was highly expressed in BLA. Next, we immunohistochemically assayed cell type specificity of the expression of NpHR-eYFP using anti-CaMKII to label glutamatergic cells and anti-GABA to label interneurons as described previously. 23, 31 We found that the cells virally transduced with NpHR-eYFP were mostly colocalized with CaMKII-positive glutamatergic cells (83 ± 4.2%, n = 3) with no overlap in GABA-positive interneurons that are neurons found in BLA 32, 33 ( Figure 1B and D) . Our results were similar to those of a previous optogenetic study using similar viral constructs in the lateral nuclei of the amygdala.
23
Green Light NpHR Activation Significantly Inhibited Glutamate Release
We next assessed the ability of light activation of NpHRexpressing cells in BLA to inhibit glutamate release using in vitro preparations. Studies were conducted in individual BLA that had received microinjections of a mixture of NpHR and ChR2, which can be activated by either green light (532 nm) or blue light (473 nm), respectively, or in controls that had received eYFP only. We first measured blue light-evoked glutamate release in a slice preparation, which preserves the local neuronal circuitry in and around BLA. As seen in Figure 1 -E, blue light evoked glutamate release from slices expressing NpHR/ChR2, whereas the same manipulation did not evoke release from slices expressing eYFP alone. This blue light-evoked release of glutamate was efficiently blocked by overlapping exposure to green light (Figure 1-F) . Other neuronal properties of the slices, for example, levels of spontaneous and depolarization evoked glutamate release (using potassium-depolarization), were equivalent across groups.
We also measured glutamate release using a synaptosome preparation. Synaptosomes are isolated nerve terminals and contain metabolically active release machinery including presynaptic active zones. Physical separation of nerve terminals from the soma and fast superfusion allow direct assessment of the effects of ChR2 and NpHR localized to the nerve terminals in and around BLA without interference from activities at dendrites, soma, glial elements, or indirect effects of released substances, for example, feedback inhibition. 34 As shown in a representative experiment (Figure 1G ), green light attenuated glutamate release from synaptosomes evoked by blue light. The average reduction was approximately 80% ( Figure 1H , F 1, 4 = 9.96, p < .04, within-subject ANOVA). Together, these experiments demonstrated that NpHR expressed in BLA attenuated glutamate release in the local neuronal circuitry and blunted activity of glutamatergic nerve terminals and thus we could efficiently inhibit in vivo glutamatergic activity in BLA.
NpHR-Mediated Peri-Shock Inhibition of BLA Significantly Increased Postshock REM and Altered the Effect of Fear Memory on Sleep
We initially assessed the general effects of shock training (ST) on sleep using eYFP mice. Results of the control experiments showed that ST induced an immediate reduction of REM in comparison to baseline (Figure 2A , lower panel, dash line box).
In an hourly analysis of 20 h postshock recording, there was a significant Treatment × Time interaction (F 19, 133 = 3.10, p < .001) with a significant reduction in REM for H1 (p < .001), H2 (p < .01), and also in total for the first 4 h (4-h block: F 12, 84 = 2.00, p < .04). Later, REM was transiently increased during the late dark period in H13 (p < .05) and H14 (p < .002) but decreased again in H15 (p < .05; Figure 2A solid line box). Figure 2C shows that total REM amount for the light-dark periods and 20 h total in recording was not significantly different from baseline recordings. As for NREM, no significant changes were found (data not shown).
In contrast, NpHR-mediated peri-shock inhibition of BLA induced an increase in postshock REM. The hourly analysis of 20-h recording revealed a significant Treatment × Time interaction (F 19, 133 = 3.28, p < .001; Figure 2B ); although REM was initially reduced during H1 (p < .001), REM had almost returned to baseline levels by H2 and was significantly increased during H4 (p < .001; Figure 2B, Figure 2D ). We did not find significant changes in total NREM ( Figure 2J and K) .
Comparison of the two groups over the first 4 h of recording revealed a significant Group × Time (H1-H4) interaction (F 3, 56 = 4.654, p = .006). Peri-shock inhibition of BLA started to attenuate the postshock REM reduction as early as H2 (p = .025), when reduction was still observed in eYFP mice. At H4 (p = .002), REM in the NpHR mice was also significantly greater than in the eYFP mice ( Figure 2B , lower panel, dash line box). Analyses of REM amounts found significant Group Main Effects for analyses of the immediate 4-h block (F 1, 14 = 4.94, p < .05), the dark period (F 1, 14 = 6.02, p < .03), and over the total 20-h recording period (F 1, 28 = 7.11, p < .02; Figure  2D ) with REM being greater in the NpHR mice in each time interval.
The post-ST REM increase found in the NpHR mice appeared to result from increases in the frequency of REM episodes. Analysis of REM episode counts found a Treatment × Time (H1-H4) interaction (F 9, 63 = 3.38, p < .003), and all pairwise comparisons revealed the number of REM episodes significantly increased during ST compared to baseline at H4. There were also Treatment × Time interactions for the dark period (F 6, 42 = 5.28, p < .002) and total 20-h recording period (F 3, 21 = 9.31, p < .002). Post hoc tests revealed the number of REM episodes were greater during ST than during baseline, CTX1, and CTX2 for both recording periods (Dark period: ST > baseline, p < .001, ST > CTX1, p < 001; ST > CTX2, p < .001; Total 20-h period: ST > baseline, p < .016, ST > CTX1, p < 007; ST > CTX2, p < .001; Figure 2E ). In addition, there was Group Main effect for REM episode duration found primarily during the first 6 h of the dark period (F 1, 70 = 10.31, p < .02).
One week and 3 weeks after ST, the animals were reexposed to the shock chamber without presenting shock to test their fear memory (CTX1 and CTX2, respectively). As with previous studies, [8] [9] [10] we found that contextual reexposure alone could alter REM. ANOVA revealed a Group × Treatment interaction (F 1, 14 = 5.68, p < .04) for comparisons of Baseline and CTX1 for total 20-h REM. REM after CTX1 was significantly greater in the NpHR mice than in the eYFP mice ( Figure 2D ), thereby indicating that peri-shock inhibition of BLA can alter the effect of fear memory on sleep, although there was no significant difference between groups during the first 4 h after context reexposure.
NpHR-Mediated Peri-Shock Inhibition of BLA did not Alter Fear Behavior or the Stress Response
Although freezing (FR) was significantly increased during CTX1 and CTX2 compared to Pre for both eYFP (F 2, 14 = 23.55, p < .001) and NpHR (F 2, 13 = 17.47, p < .001) mice ( Figure 2F and G), and moreover, eYFP mice expressed significantly less freezing on CTX2 compared to CTX1 (p < .05), there were no significant differences in FR between eYFP and NpHR mice.
The temperature data showed Treatment × Time interactions for both groups (eYFP: F 9, 63 = 4.98, p < .001; NpHR: F 9, 63 = 7.31, p < .001) where ST and subsequent CTX1 and CTX2 induced similar SIH in eYFP and NpHR mice ( Figure 2H and I) lasting 2-3 h before returning to nonstress levels. SIH following CTX1 and CTX2 was not as pronounced as that observed following ST. The SIH response did not differ in the eYFP and NpHR mice.
NpHR-Mediated Inhibition of BLA Can Facilitate REM Under Nonfearful Conditions
To determine whether the optogenetic manipulation used in this study alters sleep under nonfearful conditions, we tested mice in their home cages by presenting brief optogenetic inhibition during spontaneous sleep. Testing was conducted across 3 consecutive days with treatments randomized across days. One day entailed the animals being tethered to an optic fiber without light presentation; data collected on that day were used as control. On the other 2 days, the animals received inhibitory light during either spontaneous REM (REM+) or NREM (NREM+). Light trials started at the second hour after tethering (H1). The animals were administered multiple trials of light during H1, H2, and H4 (H3 and H5 were trial controls). Figure 3A shows representative results from one NpHR mouse demonstrating the distribution of REM during the recording period (green arrows indicate light presentation). As shown in the bottom panel and expanded EEG trace, optogenetic inhibition of BLA during spontaneous REM increased REM episode frequency, but similar inhibition during NREM (middle panel) produced no noticeable changes in either NREM or REM.
Statistical analysis of the effects of BLA inhibition on REM in NpHR mice found a Treatment × Time interaction (F 10, 58 = 3.12, p < .004; Figure 3B ). Following light treatment, the number of REM episodes increased during H1 and H2 compared to tether only and to NREM+. The REM potentiating effect was only observed within a limited time window, as inhibition of BLA did not increase REM episodes when presented during H4 ( Figure 3B ). Identical light treatment did not produce any noticeable changes in REM episodes in the eYFP mice ( Figure  3C ). Optogenetic inhibition of BLA during NREM did not alter either REM or NREM (data not shown).
The reason for the time-limited effect of BLA inhibition on REM is not entirely clear. However, plots of the 3-day average temperature (Figure 3B , shown as dotted line) show significant increases during the times when optogenetic inhibition of BLA effectively enhanced REM, whereas there was no effect on REM in the eYFP mice regardless of temperature ( Figure 3C ). This suggests a possible relationship between the ability of BLA inhibition to enhance REM and ongoing stress level but would require additional studies to confirm.
NpHR-Mediated Peri-Shock Inhibition of BLAAltered Neural Activity in BLA, CNA, and mPFC as well as in Brain Stem Regions Involved in REM Regulation
Our sleep studies demonstrated that peri-shock inhibition of BLA produced alterations in REM that occurred as early as 2 h after ST (H2, Figure 2A and B) , when the shock-induced reduction in REM was significantly attenuated in NpHR mice compared to control mice. To determine how these changes in REM were associated with neuronal activity in stress and sleep related neural circuitry, we examined c-Fos (a widely used marker of neuronal activation; e.g. 35, 36 ) in select brain regions at 2 h post-ST. Brain regions were selected based on putative functional importance in REM regulation 30 and included the amygdala (BLA and CNA), DRN, LC, LDTg, and PPTg. We also examined the mPFC, a region involved in determining the consequences of stress and coping, and which has prominent reciprocal connections with BLA. 37 The somatosensory cortex (SC) which has almost no direct afferents from BLA 38 was examined as a control region. Peri-shock BLA inhibition induced significant changes in neural activity in the amygdala (F 1, 9 = 6.415, p < .04). Subsequent analysis of subregions found that c-Fos was prominently increased in CNA (F 1, 9 = 13.876, p < .006; Figures 4A and 5A ) and reduced primarily in the posterior division of BLA (BLA-p; F 1, 10 = 7.69, p < .01; Figure 4B ) in NpHR mice compared to eYFP mice.
As shown in Figures 4C and 5B, peri-shock inhibition of BLA in NpHR mice led to increased c-Fos in mPFC (F 1, 15 = 15.13, p < .002). Also, the treatment altered activity in select brain stem regions. Neural activity increased in LDTg (F 1, 6 = 6.62, p < .05) and reduced in DRN (F 1, 9 = 5.15, p < .05; Figure 5C ). 
DISCUSSION
BLA Involvement in REM Regulation
We found that brief NpHR-mediated inhibition of glutamatergic cells in BLA during fear conditioning enhanced post-ST REM and altered the subsequent effect of fear memory on REM. The collective findings of this study provide significant experimental evidence of critical roles for BLA in mediating the effects of stress on REM and in the development of stress-related memories that can impact REM. We also found that this optogenetic manipulation can significantly alter neural activity (as indicated by c-Fos) in circuitry involved in mediating the stress response and its effects on subsequent REM. The influence of BLA on REM may not be limited to conditioned fear, as brief inhibition of BLA during spontaneous REM could augment REM. Even under this nonfear condition, the involvement of BLA on REM regulation appeared to depend on the stress state of the animal, for effective enhancement of REM time correlated with stress-induced hyperthermia, although further study will be required to evaluate this possibility.
The current results also demonstrate that the behavioral fear response (freezing) and acute stress response (SIH) are neither predictive of nor predicted by post-ST alterations in sleep. This effect of BLA inhibition on REM was independent of the acute stress response because the magnitude of SIH after ST and reexposure to the shock context alone (CTX1 and CTX2) was equivalent in the NpHR and eYFP mice. SIH occurs in all mammals including humans in preparation for fight-or-flight reactions 11 and the time course of SIH parallels that of HPA axis activation. As such it has been used as a measure of acute stress response. [39] [40] [41] Since anxiolytic drugs produce a dose-dependent reduction in the SIH response, 42 and there is a linear relationship between stressor intensity and magnitude of the SIH response, 43 treatment-induced decreases and increases in SIH are interpreted as anxiolytic or anxiogenic, respectively, with the caveat that the anxiogenic response may be limited by an SIH ceiling effect. 11 Thus, the results of SIH after ST and reexposure to context demonstrate that BLA inhibition mediated changes in REM can be independent of the peripheral stress response. Moreover, NpHR-mediated BLA inhibition did not significantly alter freezing compared with eYFP group on either the ST or the context reexposure days. Behavioral freezing has been used to evaluate fear memory, with greater freezing being interpreted as indication of stronger fear reaction. 12, 44 Thus, our results demonstrate that fear response was intact after BLA inhibition and was dissociated from post-ST sleep.
The finding that sleep disturbances can be dissociated from fear response and stress response is consistent with previous studies from our lab. For example, yoked training with escapable and inescapable footshock in mice induced directionally different modulation of poststress REM while maintaining almost identical levels of HPA activation (determined by plasma corticosterone and SIH) and behavioral fear (determined by freezing). 9 Previous studies have shown that BLA plays a role in acquiring and expressing behavioral fear. For examples, the NMDA receptor antagonist, D,L-2-amino-5-phosphonovaleric acid (APV), infused into BLA prior to ST or prior to context reexposure blocked the acquisition and expression of freezing, respectively. 45, 46 The results may appear to be inconsistent with our findings; however, we have found that inactivation of BLA with the GABA A agonist, muscimol, prior to ST in our paradigm blocks both freezing and fear-induced reductions in REM, 19 whereas inactivation after ST blocks only fear-conditioned reductions in REM. 47 Interestingly, post-ST administration of APV into BLA also does not block freezing. 46 Thus, outcomes may differ depending on the time of BLA manipulation.
While the effects of BLA inhibition on REM increase are pronounced, the potential functional importance of REM in mediating the consequences of fearful and stressful experiences has not been established, although REM is positively correlated with memory consolidation in some situations. 48, 49 The complexity of the relationship between REM, fear, and stress is apparent in research on sleep disturbances in PTSD and in suggestions regarding the potential role that REM may play in the disorder. Various studies have reported enhanced, disturbed, and relatively normal REM in PTSD patients, 50 and Mellman et al. 2, 3 have made the point that studies conducted months, years, or even decades after the traumatic event may be influenced by factors not related to the development of PTSD. They have also suggested 51 that PTSD may be associated with initial trauma-induced reductions in REM followed by increases over time as secondary processes promote REM in ways that may benefit recovery. By comparison, Ross 50 has suggested that altered REM occurring long after experiencing trauma may be pathological and signify poor adaptation to a severe stressor. Others, based on positive correlations of REM amounts with fear recall in human subjects, have suggested that REM sleep deprivation be considered as a means to attenuate fear memory associated with distressing events. 48 We have found that REM can be either increased or decreased in association with specific stressor characteristics or experimental parameters of conditioned fear, 25 but neither increases nor decreases in REM alone are predictive of the expression of fear memory elicited by reexposure to the shock context. 10 However, consistent results of REM increase after controllable stress but not after uncontrollable stress 9, 13 and in association with fear extinction in animal model 52 suggest critical roles of post-ST REM in fear regulation. This notion is compatible with hypotheses that REM is important for processing emotional 14, 15 and traumatic memories.
2,3 REM-related phasic pontine wave 53 and hippocampal theta activity 54 have been implicated in memory processing rather than REM per se, suggesting that some of the effects of manipulating BLA may be mediated via neural circuitry involved in REM regulation.
Changes in c-Fos Expression in Stress and Arousal Neurocircuitry
The effects of peri-shock BLA inhibition on REM were first observable at 2 h after ST (H2) when the immediate post-ST reduction in REM found in control mice was significantly attenuated in NpHR mice. To determine other brain areas potentially involved in mediating this difference, we examined c-Fos (a widely used marker of neuronal activation; e.g. 35, 36 ) in select brain regions at 2 h post-ST. We found that relatively brief and transient peri-shock inhibition of BLA can significantly alter c-Fos activity in BLA, CNA, mPFC, and brain stem regions involved in REM generation.
In BLA, inhibition decreased neuronal activity in the posterior (BLA-p) division but did not significantly alter c-Fos in the anterior (BLA-a) division. BLA-a consists of magnocellular and intermediate subdivisions, whereas BLA-p is primarily parvicellular. 55 Of approximately 47 000 total neurons in the entire BLA, around one-third are in the magnocellular and intermediate subdivisions, thereby making the parvicellular subdivision relatively dense. 56 Thus, differences in c-Fos in BLA across divisions may follow the anatomical heterogeneity of the region as the changes were more detectable in BLA-p, which also is the origin of the heaviest efferent projections based on anterograde tracer studies (reviewed in 55 ). BLA, together with the lateral amygdala (LA), regulates the flow of information to CNA primarily via indirect glutamatergic excitation of GABAergic neurons in the intercalated cell masses or lateral CNA neurons (reviewed in 57 ). Thus, our finding of an NpHR-induced increase in neuronal activity in CNA relative to that observed in the control mice is consistent with the intra-amygdaloid connectivity. CNA neurons fire in response to footshock, 57 and some, 35, 58 but not all, 30 studies have reported increased c-Fos in CNA in response to conditioned stimuli. Activation of CNA appears to induce the generation of fear behavior and physiological responses via descending brain stem projections, 59 for example, electrical stimulation of CNA can promote REM in some situations whereas its inhibition suppresses REM. 60 Our previous work also demonstrated linkage between increased c-Fos in CNA and increased REM, and we found that functional activation of CNA by blocking GABAergic inhibition with the GABA A antagonist bicuculline attenuates shock-induced reductions in REM, whereas inactivation of CNA using the GABA A agonist muscimol does not. 18 BLA has well-documented reciprocal connections with mPFC, 37 a region linked to the mediation of the consequence of stress and coping and in the perception of stressor controllability. 61 One of the interesting findings in this study was that peri-shock BLA inhibition led to c-Fos activation in mPFC. The mPFC is connected with DRN 37 and LC 62 and can exert topdown control over them. Since serotonergic neurons in DRN and noradrenergic neurons in LC cease firing during REM, 63 suppression of either DRN or LC could promote REM. Prefrontal inputs in DRN primarily onto GABAergic interneurons as well as glutamatergic and serotonergic neurons 64, 65 ; thus, PFC stimulation can inhibit firing in DRN. 66 In contrast, LC does not include GABAergic cell bodies, as its cells in rodents are almost exclusively noradrenergic, 67 and PFC inputs to LC synapse onto the dendrites of noradrenergic neurons in the peri-LC region. 62 As a result, PFC stimulation promotes activity in LC. 68 Our results of decreased activity in DRN, but not in LC, makes it tempting to speculate about the mechanisms underlying REM regulation based on the anatomical evidence of selective innervation of DRN and LC by mPFC. However, generation of REM is more complex and is associated with concurrent activation of "REM-on" cholinergic neurons in LDTg and PPTg together with cessation of firing in "REM-off " neurons, 63 and both types of neurons receive direct projections from CNA. Future work will be required to address the potential mechanism underlying BLA-depending REM regulation.
Optogenetics and Glutamate Release in BLA
In the current study, we took a neurochemical approach and assayed neurotransmitter release in response to light in order to verify the effect of optogenetic manipulations. Optogenetic inhibition of NpHR/ChR2-expressing cells significantly reduced optogenetic stimulation evoked glutamate release from slices and isolated nerve terminals (synaptosomes) prepared from BLA. Regulation of glutamate release at the local level is quite complex. Light in BLA slices could potentially produce depolarization/hyperpolarization of the whole pyramidal cell as well as in its axon collaterals. In addition, even if a cell was not expressing ChR2 channels, it could have modulated glutamate release upon receiving a light-evoked excitatory input from a pyramidal cell that was expressing ChR2. For example, if the cell released excitatory neurotransmitter, for example, another pyramidal cell, the response would be enhanced, and if it released inhibitory neurotransmitter, for example, GABAergic interneurons synapsing with pyramidal cells, the response would be smaller. Thus, the reported release was the results of summation of local activities. By comparison, the extent of light-evoked glutamate release from synaptosomes (nerve terminals of pyramidal cell axon collaterals) was independent of any local circuitry and directly reflected the release state of those terminals only that expressed opsins. Overall, our results allow us to state that light activation of pyramidal cells that express ChR2 in the cell body, axons, and axon terminals produce depolarization leading to glutamate release despite negative feedback regulation that is partially maintained in a slice preparation. However, they do not provide further details on specific mechanisms that regulate glutamate release within BLA.
Recording neuronal firing has been commonly used to verify the effect of optogenetic manipulations. 23, 24 We did not record neuronal firing in this study as the efficacy of the constructs we used in this study in altering firing in glutamate neurons has previously been verified. 69 The approach we used also would not replace this type of recording, but it could be used as a complementary method and would have utility for probing for the identity of neurotransmitters in uncharacterized circuits.
CONCLUSION
In conclusion, the present study adds to the growing body of work demonstrating that the BLA is an important regulator of the complex relationship between sleep, stress, and fear memory. Its role appears to include mediating both the effects of the initial stressful experience and the formation of memories that can produce effects on REM. The strong impact on REM, a sleep state implicated in the processing of emotion, suggests an important role for BLA in mediating adaptive or maladaptive responses to stress and fearful events. Critical questions remain as to the role REM may play in mediating stress outcomes and the mechanisms by which BLA mediates those outcomes.
